Ruyang County People's Hospital
Luoyang, Henan, China
NCT Number: NCT06427096
This is a 1:1 parallel design, multi-center, cluster-randomized control trial. A total of 80 villages in Ruyang County, Henan Province, China, will be randomly assigned to the intervention group or control group. At least 100 participants from 30-50 families in each village will be included in this study. The intervention group will engage in a variety of strategies, including educating a healthy lifestyle, adopting a low-sodium diet, managing weight, participating in physical exercise, monitoring blood pressure, and undergoing antihypertensive treatment. These efforts will be led by family health instructors from the community. The control group will receive usual care. The primary endpoint of this study is the change of systolic blood pressure from baseline to 6 months, reported as the difference between intervention and control group.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
Luoyang, Henan, China
This cluster-randomized control trial aims to randomly allocate 80 villages in Ruyan County to either receive a multifaceted intervention led by family health instructors or continue with usual care. Each village will recruit around 100 individuals aged 40-80 years, with or without hypertension. In intervention villages, a blood pressure management team, headed by family health instructors and family leaders, will implement various strategies including promoting a low-sodium diet, weight management, physical exercise, blood pressure monitoring, and administering antihypertensive treatment. The intervention will span 6 months, followed by another 6-month follow-up period. The primary hypothesis posits that the mean systolic blood pressure change from baseline to 6 months will be higher in the intervention group compared to the control group. The objective of this "Health Family Program" is to evaluate the efficacy of a non-healthcare provider-led multifaceted intervention in enhancing healthy lifestyles and managing blood pressure among rural residents, regardless of their hypertension status, in China.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Villages were eligible for inclusion if they had ≥200 permanent households, with ≥60 households comprising ≥2 family members.
Inclusion criteria
Exclusion criteria
3.Inclusion and Exclusion Criteria for the Family Member
Inclusion criteria
Exclusion criteria
The multifaceted interventions is comprised of the following components:
Time frame: 6 months
The systolic blood pressure changes from baseline to 6 months for all villagers, reported as the difference between intervention and control group.
Time frame: 12 months
The systolic blood pressure changes from baseline to 12 months, reported as the difference between intervention and control group.
Time frame: 6 months
The diastolic blood pressure changes from baseline to 6 months, reported as the difference between intervention and control group.
Time frame: 6 months
The proportion of participants with SBP<130 or DBP<80 mmHg at 6 months
Time frame: 6 months
The proportion of participants with antihypertensive therapy at 6 months
Heart Health Research Center
Other
Effect of Healthy Family Program on Population Blood Pressure: A 1:1 Parallel Design, Multi-Center Cluster Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04817137
Blood Pressure
Boston, Massachusetts, United States
View Trial DetailsNCT07713576
Blood Pressure
Chenzhou, Hunan, China
View Trial DetailsNCT06550297
Blood Pressure, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT07317648
Blood Pressure
York, England, United Kingdom
View Trial Details